Gilead PAP Changes
What is Changing: Implementation Extended to January 31, 2025: Effective January 31, 2025, Gilead’s Patient Assistance Programs (PAPs), including Advancing Access, will stop providing free medications for medicines where there…
Sanofi Pauses Rebate Model; Files Lawsuit Against HRSA
On December 16, Sanofi informed HRSA that it will pause the implementation of its rebate model, termed a “340B credit model.” The same day, Sanofi filed a lawsuit in the…
HRSA Warns Sanofi Over Proposed Rebate Model; Alludes to Possible Termination of Pharmaceutical Pricing Agreement (PPA)
On December 13th, the Health Resources and Services Administration (HRSA) issued a letter to Sanofi calling for the manufacturer to cease implementation of its rebate model, which Sanofi terms a…
SCOTUS Declines to Review Important Appellate Decision Protecting 340B Contract Pharmacy Arrangements in Arkansas
Yesterday, the Supreme Court denied PhRMA’s request for review of the Eighth Circuit’s decision upholding Arkansas Act 1103, which requires delivery of 340B drugs to an unlimited number of contract…
Bristol-Myers Squibb Sues To Implement Rebate Model; AbbVie Adds Grantees To Its Contract Pharmacy Policy
Bristol-Myers Squibb Sues HHS To Implement 340B Rebate Model On November 26, 2024, Bristol-Myers Squibb (BMS) filed a lawsuit against HRSA in the D.C. District Court to defend its proposed…
Sanofi Announces Rebate Model; All Eyes on Whether HHS Will Threaten to Terminate It from Medicaid and Medicare
On November 25, 2024, Sanofi became the third manufacturer to announce its intention to implement a rebate model. Its announcement follows similar announcements from Johnson & Johnson (J&J) and Eli…
Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model
11/19/2024 – Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model On November 14, 2024, Eli Lilly and Company (Lilly) filed a lawsuit against HHS and HRSA in…
J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model
11/14/2024 – J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model On November 12, 2024, Johnson and Johnson Health Care System Inc. (J&J) filed a lawsuit…
CMS Releases Physician Fee Schedule Final Rule for Calendar Year 2025 with Wins and Losses for Covered Entities
11/8/2024 – CMS Releases Physician Fee Schedule Final Rule for Calendar Year 2025 with Wins and Losses for Covered Entities On Friday November 1, 2024, CMS published the Calendar Year…
Boehringer Ingelheim Will Require Claims Data Submission for Single Contract Pharmacy
11/5/2024 – Beginning December 2, 2024, Boehringer Ingelheim Pharmaceuticals, Inc. (BI) will require covered entities to submit 340B claims data to 340B ESP™ for a single contract pharmacy. This policy applies…